<DOC>
	<DOCNO>NCT00097422</DOCNO>
	<brief_summary>The purpose study investigate safety perform preliminary clinical evaluation patient mild moderate CDAD .</brief_summary>
	<brief_title>OPT-80 Clostridium Difficile-Associated Diarrhea ( CDAD )</brief_title>
	<detailed_description>This dose-finding study select safe efficacious dose OPT-80 . Patients evaluate safety efficacy pharmacokinetic parameter investigate .</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<criteria>Patients CDAD Patients severe CDAD</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>CDAD , diarrhea</keyword>
	<keyword>Clostridium difficile-Associated Diarrhea</keyword>
</DOC>